News · 26 weeks69+250%
2026-04-192026-10-11
Mix2290d
- Other9(41%)
- Insider8(36%)
- SEC Filings3(14%)
- Earnings2(9%)
Latest news
25 items- SECSEC Form 8-K filed by Medline Inc.8-K - Medline Inc. (0002046386) (Filer)
- PRMedline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.State-of-the-art facility planned to reinforce Medline's supply chain resilience in MichiganNORTHFIELD, Ill., Oct. 15, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, has announced plans to open a new distribution center in Van Buren Township, Mich., a suburb of Detroit. The approximately 800,000-square-foot facility represents a new company investment in Michigan and the overall Medline distribution network, adding capacity and operational flexibility as Medline invests to support its own growth and the evolving needs of healthcare providers across all points of care."This investment in Van
- INSIDERSEC Form 4 filed by Medline Inc.4 - Medline Inc. (0002046386) (Issuer)
- PRMedline launches enhanced TrackPoint™ to simplify inventory management for post-acute careCombines real-time inventory tracking with PointClickCare® integration to reduce manual work and improve supply visibilityNORTHFIELD, Ill., Oct. 12, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) today announced the launch of an enhanced version of TrackPoint™, its online inventory management and patient item usage solution designed to help long-term care and inpatient hospice providers more easily track supplies from Medline, capture patient-level usage and gain visibility into inventory across locations.TrackPoint provides an easy-to-use solution that helps facilities streamline how they order and manage supplies purchased from Medline. The platform gives providers greater control over supply
- INSIDERSEC Form 4 filed by Medline Inc.4 - Medline Inc. (0002046386) (Issuer)
- PRMEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share DropThe law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Medline Inc. ("Medline" or the "Company") (NASDAQ:MDLN) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE FIRM’S INVESTIGATION]What Happened?On June 2, 2026, the FDA published a warning letter that detailed Medline’s "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals," including failing "to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications
- PRMedline to report third quarter 2026 results on November 4, 2026NORTHFIELD, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report third quarter 2026 financial results on Wednesday, November 4, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline’s financial results, including a link to the live webcast, will be available on the Events page of Medline’s Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedline is the larges
- PRINVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law FirmMedline Inc. (NASDAQ:MDLN) shareholders should email fletcher@fmoorelaw.com NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- What is the Investigation About? On June 2, 2026, the Federal Drug Administration ("FDA") published a warning letter dated May 28, 2026 addressed to Medline summarizing "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals[.]" The FDA further states that Medline "failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications." Following this news, the price of Medline stock fell $2.56 per share, or 7.16%, to close at $33.19 per share on Ju
- PRMedline announces participation in the Morgan Stanley 24th Annual Global Healthcare ConferenceNORTHFIELD, Ill., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY, on Tuesday, September 15, 2026, at 12:20pm ET. A webcast of the presentation will be available on the Events page of Medline’s Investor Relations website at ir.medline.com. A replay of the webcast will be available on Medline’s Investor Relations website for 90 days following the event. About MedlineMedline is the largest provider of medical-surgical products and supply chain solutions serving all
- INSIDERSEC Form 4 filed by Chief Executive Officer Boyle James M4 - Medline Inc. (0002046386) (Issuer)
- INSIDERSEC Form 4 filed by Chief Operating Officer Miller Stephen L4 - Medline Inc. (0002046386) (Issuer)
- INSIDERLarge owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.SCHEDULE 13G/A - Medline Inc. (0002046386) (Subject)
- INSIDERLarge owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERLarge owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.SCHEDULE 13G/A - Medline Inc. (0002046386) (Subject)
- INSIDERLarge owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- SECSEC Form SCHEDULE 13G filed by Medline Inc.SCHEDULE 13G - Medline Inc. (0002046386) (Subject)
- SECSEC Form 10-Q filed by Medline Inc.10-Q - Medline Inc. (0002046386) (Filer)
- SECMedline Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Medline Inc. (0002046386) (Filer)
- PRMedline Reports Second Quarter and First Six Months 2026 ResultsSecond quarter net sales of $7.7 billion, an increase of 11.6%Second quarter net income of $139 million, a decrease of 58.3%Second quarter Adjusted EBITDA1 of $1.1 billion, an increase of 13.4%First six months net sales of $15.0 billion, an increase of 11.1%First six months net income of $378 million, a decrease of 42.3%First six months Adjusted EBITDA1 of $1.8 billion, an increase of 1.9%Updating full year 2026 Organic Sales2 guidance to 9.0% to 10.0% and Adjusted EBITDA2 guidance to $3.3 billion to $3.4 billionSecond quarter and first six months net sales included $89 million of IEEPA tariff customer repaymentsSecond quarter and first six months net income and Adjusted EBITDA1 included $24
- PRMedline strengthens California distribution network with new 1 million-square-foot facility in PerrisCutting-edge distribution center to reinforce Medline's supply chain resilience in CaliforniaNORTHFIELD, Ill., July 20, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) has announced plans to open a new distribution center in Perris, Calif. The approximately 1 million-square-foot facility represents another company investment in its California and overall distribution network, adding capacity and operational flexibility to support healthcare providers across the state. "This investment marks another step in the continued growth of our California distribution network," said Jim Eveland, vice president of regional operations at Medline
- SECMedline Inc. filed SEC Form 8-K: Leadership Update8-K - Medline Inc. (0002046386) (Filer)
- PRMedline announces Prime Vendor agreement with Allina HealthAgreement provides access to Medline's medical-surgical products and supply chain solution offerings. NORTHFIELD, Ill., July 8, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Allina Health, a healthcare system based in Minneapolis that provides care to communities across Minnesota and western Wisconsin through its network of 12 hospital campuses and more than 90 clinics. Through this agreement, Allina Health will have access to Medline's comprehensive portfolio of medical-surgical products for its hospital and physician office sites, as well as powerful distribution c
- PRSecuring new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern CaliforniaMassive new medical supplies distribution space represents 45% expansion of Medline's customer-facing NorCal footprintNORTHFIELD, Ill., July 6, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) has announced a lease agreement for an existing 925,000-square-foot warehouse in Tracy, Calif., for immediate occupancy, as well as a 709,000-square-foot facility nearby in Stockton, Calif., for use in January 2027. These two facilities total more than 1.6 million square feet of new medical supplies distribution center space and more than supplant the 1 million-square-foot Tracy facility that was destroyed by fire on June 11. This new capacity to serve regional healthcare providers also represents a 45% expa
MDLN FAQ
6 questionsWhere does MDLN stock trade?
Medline Inc. (MDLN) is listed on NASDAQ.What sector and industry is MDLN in?
Medline Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Medline Inc. go public?
Medline Inc. (MDLN) completed its IPO in 2025.What are analysts saying about MDLN?
Medline Inc. has had 8 recent analyst actions on file. The most recent action was from Citigroup: Buy on 2026-03-11. Recent price targets range from $3800.00 to $4800.00.What companies are similar to MDLN?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), RMD (ResMed Inc.). Compare MDLN side-by-side with any of them on Quantisnow.How can I track MDLN on Quantisnow?
Quantisnow aggregates Medline Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MDLN to receive live email and push alerts on every new disclosure.